جاهز للتشغيل
جاهز للتشغيل
A recent study has shown that the use of GLP-1 medications, intended for the treatment of type 2 diabetes and obesity, is associated with a reduced risk of liver complications. The study confirmed that these drugs may help improve liver health and decrease related complications in patients, thereby reinforcing their role in managing associated chronic conditions.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading